Background:  This is a multicenter, randomized, double-blind, active-controlled study to evaluate the effects of LCZ696 compared to valsartan on cognitive function in patients with chronic heart failure and preserved ejection fraction Sponsor: Novartis Trial Registration No: NCT02884206 (clinicaltrials.gov) Link  Trial Status: recruiting  Enrolling Centers:  Worldwide: 17 countries Core Study Team: 
© Christian Mueller, 2012 - 2017  │  Disclaimer  │  Imprint  │  Webmaster │ Last Update: November 2017
Home News Team Studies Publications Events Cooperations Contact Dr. Samyut Shrestha Brigitte Fitze Jonas Schwarz Janine Vögele Deborah Müller Rahel Isenrich Ina-Maria Ferel Kristin Shrestha Jeanne Du Fay de Lavallaz Aymann Alhussini Michael Freese